|
1
|
Wang X, Guo B, Li Q, Peng J, Yang Z, Wang
A, Li D, Hou Z, Lv K, Kan G, et al: miR-214 targets ATF4 to inhibit
bone formation. Nat Med. 19:93–100. 2013. View Article : Google Scholar
|
|
2
|
Lewis BP, Burge CB, Bartel DP, et al:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120. pp.
15–20. 2005, View Article : Google Scholar
|
|
3
|
Doench JG, Sharp PA, et al: Specificity of
microRNA target selection in translational repression. Genes Dev.
18:504–511. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eskildsen T, Taipaleenmäki H, Stenvang J,
Abdallah BM, Ditzel N, Nossent AY, Bak M, Kauppinen S, Kassem M, et
al: MicroRNA-138 regulates osteogenic differentiation of human
stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA.
108:6139–6144. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dong J, Cui X, Jiang Z, Sun J, et al:
MicroRNA-23a modulates tumor necrosis factor-alpha-induced
osteoblasts apoptosis by directly targeting Fas. J Cell Biochem.
114:2738–2745. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hassan MQ, Maeda Y, Taipaleenmaki H, Zhang
W, Jafferji M, Gordon JA, Li Z, Croce CM, van Wijnen AJ, Stein JL,
et al: miR-218 directs a Wnt signaling circuit to promote
differentiation of osteoblasts and osteomimicry of metastatic
cancer cells. J Biol Chem. 287:42084–42092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu R, Li H, Liu W, Yang L, Tan YF, Luo XH,
et al: Targeting miRNAs in osteoblast differentiation and bone
formation. Expert Opin Ther Targets. 14:1109–1120. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Inose H, Ochi H, Kimura A, Fujita K, Xu R,
Sato S, Iwasaki M, Sunamura S, Takeuchi Y, Fukumoto S, et al: A
microRNA regulatory mechanism of osteoblast differentiation. Proc
Natl Acad Sci USA. 106:20794–20799. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li H, Xie H, Liu W, Hu R, Huang B, Tan YF,
Xu K, Sheng ZF, Zhou HD, Wu XP, Luo XH, et al: A novel microRNA
targeting HDAC5 regulates osteoblast differentiation in mice and
contributes to primary osteoporosis in humans. J Clin Invest.
119:3666–3677. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Busacca S, Germano S, De Cecco L, Rinaldi
M, Comoglio F, Favero F, Murer B, Mutti L, Pierotti M, Gaudino G,
et al: MicroRNA signature of malignant mesothelioma with potential
diagnostic and prognostic implications. Am J Respir Cell Mol Biol.
42:312–319. 2010. View Article : Google Scholar
|
|
11
|
Chan JA, Krichevsky AM, Kosik KS, et al:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang SS, Jiang WW, Smith I, Poeta LM,
Begum S, Glazer C, Shan S, Westra W, Sidransky D, Califano JA, et
al: MicroRNA alterations in head and neck squamous cell carcinoma.
Int J Cancer. 123:2791–2797. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hatley ME, Patrick DM, Garcia MR,
Richardson JA, Bassel-Duby R, van Rooij E, Olson EN, et al:
Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.
Cancer Cell. 18:282–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krichevsky AM, Gabriely G, et al: miR-21:
a small multi-faceted RNA. J Cell Mol Med. 13:39–53. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ladeiro Y, Couchy G, Balabaud C,
Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J, et al:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47. pp. 1955–1963. 2008, View Article : Google Scholar
|
|
16
|
Moriyama T, Ohuchida K, Mizumoto K, Yu J,
Sato N, Nabae T, Takahata S, Toma H, Nagai E, Tanaka M, et al:
MicroRNA-21 modulates biological functions of pancreatic cancer
cells including their proliferation, invasion, and chemoresistance.
Mol Cancer Ther. 8:1067–1074. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY, et
al: miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007.
View Article : Google Scholar
|
|
18
|
Zhu S, Si ML, Wu H, Mo YY, et al:
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).
J Biol Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY,
et al: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Z, Hassan MQ, Volinia S, van Wijnen AJ,
Stein JL, Croce CM, Lian JB, Stein GS, et al: A microRNA signature
for a BMP2-induced osteoblast lineage commitment program. Proc Natl
Acad Sci USA. 105:13906–13911. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Itoh T, Takeda S, Akao Y, et al:
MicroRNA-208 modulates BMP-2-stimulated mouse preosteoblast
differentiation by directly targeting V-ets erythroblastosis virus
E26 oncogene homolog 1. J Biol Chem. 285:27745–27752. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kuree J, Dixit M, Tyagi AM, Mansoori MN,
Srivastava K, Raghuvanshi A, Maurya R, Trivedi R, Goel A and Singh
D: miR-542-3p suppresses osteoblast cell proliferation and
differentiation, targets BMP-7 signaling and inhibits bone
formation. Cell Death Dis. February 6–2014.Epub ahead of print.
View Article : Google Scholar
|
|
23
|
Mei Y, Bian C, Li J, Du Z, Zhou H, Yang Z,
Zhao RC, et al: miR-21 modulates the ERK-MAPK signaling pathway by
regulating SPRY2 expression during human mesenchymal stem cell
differentiation. J Cell Biochem. 114:1374–1384. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang N, Wang G, Hu C, Shi Y, Liao L, Shi
S, Cai Y, Cheng S, Wang X, Liu Y, et al: Tumor necrosis factor α
suppresses the mesenchymal stem cell osteogenesis promoter miR-21
in estrogen deficiency-induced osteoporosis. J Bone Miner Res.
28:559–574. 2013. View Article : Google Scholar
|
|
25
|
Wang RN, Green J, Wang Z, Deng Y, Qiao M,
Peabody M, Zhang Q, Ye J, Yan Z, Denduluri S, et al: Bone
Morphogenetic Protein (BMP) signaling in development and human
diseases. Genes Dis. 1:87–105. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Min S, Liang X, Zhang M, Zhang Y, Mei S,
Liu J, Liu J, Su X, Cao S, Zhong X, et al: Multiple
tumor-associated microRNAs modulate the survival and longevity of
dendritic cells by targeting YWHAZ and Bcl2 signaling pathways. J
Immunol. 190:2437–2446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang N, Song W-X, Luo J, Luo X, Chen J,
Sharff KA, Bi Y, He BC, Huang JY, Zhu GH, et al: BMP-9-induced
osteogenic differentiation of mesenchymal progenitors requires
functional canonical Wnt/β-catenin signalling. J Cell Mol Med.
13(8B): 2448–2464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Amin S, Riggs BL, Melton LJ III, Achenbach
SJ, Atkinson EJ, Khosla S, et al: High serum IGFBP-2 is predictive
of increased bone turnover in aging men and women. J Bone Miner
Res. 22:799–807. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou H, Zou S, Lan Y, Fei W, Jiang R, Hu
J, et al: Smad7 modulates TGFβ signaling during cranial suture
development to maintain suture patency. J Bone Miner Res.
29:716–724. 2014. View Article : Google Scholar
|
|
30
|
Luther G, Wagner ER, Zhu G, Kang Q, Luo Q,
Lamplot J, Bi Y, Luo X, Luo J, Teven C, et al: BMP-9 induced
osteogenic differentiation of mesenchymal stem cells: molecular
mechanism and therapeutic potential. Curr Gene Ther. 11:229–240.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng H, Jiang W, Phillips FM, Haydon RC,
Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, et al:
Osteogenic activity of the fourteen types of human bone
morphogenetic proteins (BMPs). J Bone Joint Surg Am.
85-A:1544–1552. 2003.PubMed/NCBI
|
|
32
|
Kang Q, Sun MH, Cheng H, Peng Y, Montag
AG, Deyrup AT, Jiang W, Luu HH, Luo J, Szatkowski JP, et al:
Characterization of the distinct orthotopic bone-forming activity
of 14 BMPs using recombinant adenovirus-mediated gene delivery.
Gene Ther. 11:1312–1320. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peng Y, Kang Q, Cheng H, Li X, Sun MH,
Jiang W, Luu HH, Park JY, Haydon RC, He TC, et al: Transcriptional
characterization of bone morphogenetic proteins (BMPs)-mediated
osteogenic signaling. J Cell Biochem. 90:1149–1165. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Peng Y, Kang Q, Luo Q, Jiang W, Si W, Liu
BA, Luu HH, Park JK, Li X, Luo J, et al: Inhibitor of DNA
binding/differentiation helix-loop-helix proteins mediate bone
morphogenetic protein-induced osteoblast differentiation of
mesenchymal stem cells. J Biol Chem. 279:32941–32949. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Luo Q, Kang Q, Si W, Jiang W, Park JK,
Peng Y, Li X, Luu HH, Luo J, Montag AG, et al: Connective tissue
growth factor (CTGF) is regulated by Wnt and bone morphogenetic
proteins signaling in osteoblast differentiation of mesenchymal
stem cells. J Biol Chem. 279:55958–55968. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sharff KA, Song WX, Luo X, Tang N, Luo J,
Chen J, Bi Y, He BC, Huang J, Li X, et al: Hey1 basic
helix-loop-helix protein plays an important role in mediating
BMP9-induced osteogenic differentiation of mesenchymal progenitor
cells. J Biol Chem. 284:649–659. 2009. View Article : Google Scholar :
|
|
37
|
Luu HH, Song WX, Luo X, Manning D, Luo J,
Deng ZL, Sharff KA, Montag AG, Haydon RC, He TC, et al: Distinct
roles of bone morphogenetic proteins in osteogenic differentiation
of mesenchymal stem cells. J Orthop Res. 25:665–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lamplot JD, Qin J, Nan G, Wang J, Liu X,
Yin L, Tomal J, Li R, Shui W, Zhang H, et al: BMP9 signaling in
stem cell differentiation and osteogenesis. Am J Stem Cells.
2:1–21. 2013.PubMed/NCBI
|
|
39
|
Yu PB, Deng DY, Lai CS, Hong CC, Cuny GD,
Bouxsein ML, Hong DW, McManus PM, Katagiri T, Sachidanandan C, et
al: BMP type I receptor inhibition reduces heterotopic
ossification. Nat Med. 14:1363–1369. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Augello A, De Bari C, et al: The
regulation of differentiation in mesenchymal stem cells. Hum Gene
Ther. 21:1226–1238. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li H, Yang F, Wang Z, Fu Q, Liang A, et
al: MicroRNA-21 promotes osteogenic differentiation by targeting
small mothers against decapentaplegic 7. Mol Med Rep. 12:1561–1567.
2015.PubMed/NCBI
|
|
42
|
Yang N, Wang G, Hu C, Shi Y, Liao L, Shi
S, Cai Y, Cheng S, Wang X, Liu Y, et al: Tumor necrosis factor α
suppresses the mesenchymal stem cell osteogenesis promoter miR-21
in estrogen deficiency-induced osteoporosis. J Bone Miner Res.
28:559–573. 2013. View Article : Google Scholar
|
